CONTEXTThe accelerator hypothesis (AH) proposed by the late Prof Terence Wilkin attempts to unite the type 1 (T1D) and type 2 diabetes (T2D) by obesity driven insulin resistance (IR) and tends, in part, to explain the rising incidence of T1D by a parallel increase in the incidence of obesity.1 Since its inception in 2001, several studies have been conducted across the world to test the validity of AH. The results of these studies have shown considerable variability with some studies confirming and others refuting or showing neutrality to the key proposals of AH. This brief communication discusses the journey of AH over the last 16 years in the light of data accumulated from studies that aimed to test relevance and applicability of AH in diverse patient populations.
KEY PREDICTIONS AND CONTROVERSIESThe AH proposes that all the three processes or accelerators i.e. IR, autoimmunity and genetic predisposition that result in presentation of diabetes (either type 1 or 2) are driven by excess weight gain, which is thought to be "the missing link" between the two types of diabetes.1 In particular, IR associated with recent weight gain is considered the main accelerator of pancreatic β-cell apoptosis that leads to earlier onset of T1D in individuals at genetic risk. The acceleration of diabetes and its presentation at a younger age will,
ABSTRACTThe incidence of Type 1 diabetes (T1D) has increased significantly over the past few decades but the causes for this increase are poorly understood and hence the strategies for preventing T1D are difficult to design. T1D is characterised by autoimmune destruction of pancreatic β-cells resulting in insulin deficiency as opposed to Type 2 diabetes (T2D) characterised by weight driven insulin resistance (IR). The accelerator hypothesis (AH), proposed by the late Prof Terence Wilkin in 2001 offers an alternative mechanism for T1D and a different approach to prevention of T1D. This hypothesis considers both T1D and T2D as one and proposes that obesity driven IR is the key factor that may lead to either type of diabetes. It thus offers an easy explanation for the increasing worldwide incidence of childhood diabetes which is paralleled by the increase in childhood obesity rates. However, one of the key predictions of AH that the obesity related IR accelerates the onset of diabetes and hence heavier children should develop diabetes at a younger age, has remained a matter of debate since the hypothesis was first proposed. Since the inception of AH, the results of a number of studies which aimed at testing the hypothesis in diverse patient populations have shown support or opposed this key prediction. This article discusses the relevance of AH in the context of data from these studies.